You are on page 1of 9

DAFTAR PUSTAKA

Adlakha, K, B. D. (1994). Paneth cell-like change in prostatic adenocarcinoma


represents neuroendocrine differentiation: report 30 cases. Hum Pathol , 135-
139.

Al, Olama AA., K.-J. Z. (2009). Multiple loci on 8q24 associated with prostate
cancer susceptibility. Nat Genet , 1058-60.

Alberts, B., Johnson, A., Lewis. J., Morgan, D., Raff, M., Roberts, K. (2008).
Molecular Biology of The Cell. Garland Sciences.

Alguacil-Garcia, A. (1986). Artifactual changes mimicking signet ring cell


carcinoma in transurethral prostatectomy specimens. Am J Surg Pathol (10),
795-800.

American Cancer Society. (2015, August 6). Cancer Facts and Figures 2015.

American Joint Committee on Cancer. (2010). Sistem TNM 2009.

Ayala, AG., Ro, JY. (2007). Prostatic intraepithelial neoplasia: recent


advances. Arch Pathol Lab Med (131), 1257-1266.

Baretton, GB., Vogt, T., Blasenbreu, S., Lohrs, U. (1994). Comparison of DNA
ploidy in prostatic intraepithelial neoplasia and invasive carcinoma of the
prostate. An image cytometric study. Hum Pathol (25), 506-513.

Baydar, D. E. (2009). Gleason Grading System,Modifications and Additions to


the Original Scheme. Turkish Journal of Pathology , 25 (3), 59-70.

Bennett, BD., Gardner, Jr WA. (1980). Crystalloids in prostatic


hyperplasia. Prostate (1), 31-35.

Bhurgri, Y., Kayani, N., Pervez, S. (2001). Incidence and trends of prostate cancer
in karachi south, 1995-2002. Asian Pac J Cancer Prev (10), 45-8.

Bishara, T., Ramnani, DM., Epstein, JI. (2005). High-grade prostatic


intraepithelial neoplasia on needle biopsy: risk of cancer on repeat biopsy

1
related to number of involved cores and morphologic pattern. Am J Surg
Pathol (28), 629-633.

Bock, BJ., Bostwick, DG. (1999). Does prostatic ductal adenocarcinoma


exist?. Am J Surg Pathol (23), 781-785.

Bok, R. A., & Small, E. J. (2002). Bloodborne molecular markers in prostate


cancer development and progression. Natural Reviews Cancer , 918-926.

Bostwick, DG., Qian J. (2004). High-grade prostatic intraepithelial


neoplasia. Mod Pathol (17), 360-379.

Brawer, MK., Bigler, SA., Sohlberg, OE., Nagle, RB., Lange, PH. (1991).
Significance of prostatic intraepithelial neoplasia on prostate needle
biopsy. Urology (38), 103-107.

Brosman, S. A. (2015). Prostate cancer and nutrition. Emedicine . Diunduh


tanggal 27 Januari 2016 dari http://emedicine.medscape.com/article/453191-
author

Canadian Cancer Society. (2016). Anatomy and physiology of the prostate.


Diunduh tanggal 27 Januari 2016 dari http://www.cancer.ca/en/cancer-
information/cancer-type/prostate/anatomy-and-physiology/?region=on

Capella, C, U. L. (1981). The endocrine component of prostatic carcinomas,


mixed adenocarcinoma-carcinoid tumours and non-tumour prostate.
histochemical and ultrastructural identification of the endocrine cells.
Histopathology (5), 175-192.

Chodak, G. W. (2015). Prostate Cancer. Emedicine . Diunduh tanggal 27 Januari


2016 dari http://emedicine.medscape.com/article/1967731-overview#a1

Christian, JD., Lamm, TC., Morrow, JF., Bostwick, DG. (2005). Corpora
amylacea in adenocarcinoma of the prostate: incidence and histology within
needle core biopsies. Mod Pathol (18), 36-39

2
Del, Rosario AD., Bui, HX., Abdulla, M., Ross, JS. (1993). Sulfur-rich prostatic
intraluminal crystalloids. A surgical pathologic and electron probe x-ray
microanalytic study. Hum Pathol (24), 1159-1167.

Epstein, JI. (1994). Pathology of prostatic intraepithelial neoplasia and


adenocarcinoma of the prostate. Prognostic influences of stage, tumor
volume, grade, and margins of resection. Semin Oncol (21), 527-541.

Eroschenko, VP. (2001). Atlas histologi di Fiore dengan korelasi fungsional.


Jakarta:EGC.

Fowler JE Jr, S. J. (2000). Percent free prostate speific antigen and cancer
detection in black and white men with total prostate specific antigen 2.5 to
9.9 ng/ml. J Urol (5), 1467-70.

Garcia, JJ.,AlAhmadie, HA., Gopalan, A., Tickoo, SK., Scardino, PT., Reuter, VE
., Fine, SW. (2008). Do prostatic transition zone tumors have a distinct
morphology?. Am J Surg Pathol (32), 1709-1714.

Grignon, D. J. (2004). Unusual subtypes of prostate cancer. Modern Pathology ,


316-327.

Guyton, A. C., & Hall, J. E. (2012). Bukur Ajar Fisiologi Kedokteran Guyton &
Hall Edisi 11 (pp. 1055-1061). (Irawati, D. Ramadhani, & et. al., Eds.)
Jakarta: EGC.

Hamawi, M. L. (2010). Gambaran Histopatologi Penyakit Benign Prostatic


Hyperplasia (BPH) dan Kanker Prostat di Laboratorium Patologi Anatomi
Rumah Sakit Umum Pusat Haji Adam Malik Medan Periode 2008-2009.
Repository USU .

Harkonen, P. L., & Makela, S. I. (2004). Role of estrogens in development of


prostate cancer. Elsevier .

Helpap, B. (1993). Review of the morphology of prostatic carcinoma with special


emphasis on subgrading and prognosis. J Urol Pathol (1), 3-19.

3
Highlights on Prostate Cancer from Urological and Oncological Congresses in
2007. (2007).

Holmes, EJ (1977). Crystalloids of prostatic carcinoma. Relationship to Bence-


Jones crystals. Cancer (39), 2073-2080.

Hsing, AW, C. G. (1993). Serological precusors of cancer : serum hormonesand


risk of subsequent prostate cancer. Cancer Epidemiol Biomarkers Prev , 27-
32.

Indonesian Society of Urologic Oncology (ISUO) meeting. (2011). Unpublished


data.

Isselbacher, K. J., Braunwald, E., Wilson, J. D., Martin, J. B., Fauci, A. S. (2014).
Prinsip-Prinsip Ilmu Penyakit Dalam Harrison (pp. 2070-2071). (A. H.
Asdie, Ed.) Jakarta: EGC.

Jennifer, R. S. (2009). Gleason Score and Lethal Prostate Cancer : Does 3+4 =
4+3? Journal of clinical Oncology , 27 (21).

Jeong, IG., Kim, CS., Ro, JY. (2012). Introduction and prostate cancer statistic.
Advances in Surgical Pathology Prostate Cancer, 3-7.

Junaidi, Fachrul (2012). Hubungan Antara Grading Histopatologi (Gleason Score)


dan Level PSA pada Kanker Prostat di Rumah Sakit Umum Pusat H. Adam
Malik - Medan. Repository USU .

Kang, DI., Chung, JI., Ha, HK. (2013). Korean prostate cancer patients have
worse disease characteristics than their american counterparts. Asian Pac J
Cancer Prev (14), 6913-7.

Kelompok Kerja Kanker Urologi RS.Cipto Mangunkusumo-RS. Kanker


Dharmais. (2009). Panduan Pengelolaan Kanker Prostat. Interna Publishing.

Kementerian Kesehatan Republik Indonesia. (2015). Panduan Nasional


Penanganan Kanker Prostat. Komite Nasional Penanggulangan Kanker
(KPKN).

4
King, R. J. (2012). Cancer Biology Ed. 2. London School of Biological Sciences,
University of Surrey.

Klein, EA., Platz, EA., Thompson, IM. (2007). Epidemiology, etiology, and
prevention of prostate cancer. WEIN AJ,Kovoussi LR, Novick A, Partin AW,
Peters CA. Ed. Campbell-Walsh Urology. Philadelphia:Saunders, 2854-73.

Kumar, V., Cotran, R. S., & Robbins, S.L. (2013). Buku Ajar Patologi Robbins
(pp. 200-201, 746-748). Jakarta: EGC.

Kuroda, Naoto., Yamasaki, Ichiro., Nakayama, Hirofumi., Tamura, Kenji.,


Yamamoto, Yukio. (2002). Prostatic signet-ring cell carcinoma: Case report
andliterature review. Pathology International, 49 (5).

Mai, KT., Collins, JP., Veinot, JP. (2002). Prostatic adenocarcinoma with
urothelial (transitional cell) carcinoma features. Appl Immunohistochem Mol
Morphol (10), 231-236.

Mescher, K. L., Dalley, A. L., & Agur, A. M. (2012). Teks dan Atlas Histologi
Dasar Junqueira Edisi 12 (pp. 374-376). Jakarta: EGC.

Mottet, N., Shatken, JA., Heidenreich, A., Bastian, PJ., Irani, J. (2008). Highlights
on Prostate Cancer from Urological and Oncological Congresses in 2007. Eur
Urol Suppl, 460-73.

Murthy, Shashidhar Venkatesh. (2015). Pathology of Prostate – Cancer. James


Cook University:Australia.

Nath, A., Singh, JK., Vendan, SE. (2012). Elevated level of prostate specific
antigen among prostat cancer patients and high prevalence in the gangetic
zone of bihar, India.Asian Pac J Cancer Prev (14), 63-8.

NCI. (2009). Prostate Cancer. Diunduh tanggal 27 Januari 2016 dari


http://www.cancer.gov/cancertopics/types/prostate.html.

Nelles, J. L., Hu, W.-Y., & Prins, G. S. (2011). Estrogen action and prostate
cancer. Expert Rev Endocrinol Metab , 6 (3), 437-451.

5
Nurse, P. (2000). A Long Twentieth Century of The Cell Cycle and Beyond. Cell
(100), 71-78.

PA, D. S. (2000). Divergent neuroendocrine differentiation in prostatic carcinoma.


Semin Diagn Pathol , 149-161.

Pan, CC., Chiang, H., Chang, YH., Epstein, JI. (2000). Tubulocystic clear cell
adenocarcinoma arising within the prostate. Am J Surg Pathol (24), 1433-
1436.

Parwani, AV., Kronz, JD., Genega, EM., Gaudin, P., Chang, S. (2004). Prostate
carcinoma with squamous differentiation: an analysis of 33 cases. Am J Surg
Pathol (28), 651-657

Pecorino, L. (2005). Molecular Biology of Cancer Mechanism Target, and


Therapeutics. London: Oxford University Press.

Purnomo, B. B. (2011). Dasar-dasar Urologi Edisi Ketiga (pp. 261-267). Malang:


Sagung Seto.

Putriyuni, A., & Hilbertina, N. (2014). Adenokarsinoma Prostat : Penilaian


Prognostik dan Derajat Histopatologi. MKA , 37 (2).

Ragunathan, Nageenthren (2014). Gambaran Pasien Kanker Prostat Di RSUP H.


Adam Malik Medan dari Januari 2012 – Desember 2013. Repository USU .

Risbridger, G. P., Ellem, S. J., & McPherson, S. J. (2007). Estrogen action on the
prostate gland : a crtical mix of endocrine and paracrine signaling. Journal of
Molecular Endrocrinology (39), 183-188.

Ro, JY., Grignon, DJ., Ayala, AG., Fernandez, PL., Ordonéz, NG. (1990).
Mucinous adenocarcinoma of the prostate. Histochemical and
immunohistochemical studies. Hum Pathol (21), 593-600.

Ro, JY, MD., El-Naggar., Adel, MD., Ayala, Alberto G, MD. (1988). Signet-
Ring-Cell Carcinoma of The Prostate: Electron Microscopic and

6
Immunohistochemical Studies of Eight Cases. The American Journal of
Surgical Pathology.

Rosai, Juan. M. (2011). Rosai and Ackerman's Surgical Pathology Tenth Edition
(pp.1295-1303). Milan, Italy: Elsevier.

Ruddon, RW. (2007). Cancer Biology. New York : Oxford University Press.

Schlesinger, C., Bostwick, DG., Iczkowski, KA. (2005). High-grade prostatic


intraepithelial neoplasia and atypical small acinar proliferation: predictive
value for cancer in current practice. Am J Surg Pathol (29), 1201-1207.

Seisen, T., Roupret, M., Faix, A. (2012). The prostate gland: a crossroad between
the urinary and the seminal tracts. Prog Urol (22), 66-80.

Shen, S. S. (2014). Pathology of transitional cell prostate carcinoma. Emedicine .

Siegel, RL, M. J. (2015). Cancer statistics. CA Cancer J Clin (1), 5-29.

Singh, H., Flores-Sandoval, N., Abrams, J. (2003). Renal-type clear cell


carcinoma occurring in the prostate. Am J Surg Pathol (27), 407-410.

Sjamsuhidajat, R., & Jong, W. D. (2014). Buku Ajar Ilmu Bedah (pp. 903-905).
Jakarta: EGC.

Sudiana, LK. (2011) Patobiologi Molekuler Kanker. Jakarta: Salemba Empat.

Totten, RS., Heinemann, MW., Hudson, PB., Sproul, EE., Stout, AP. (1953).
Microscopic differential diagnosis of latent carcinoma of the prostate. Arch
Pathol (55), 131-141.

Tsao, A. S., Kim, E. S., dan Hong, W. K. 920040. Chemoprevention of cancer. ca


cancer Journal for Clinicians, 54, 150-180.

Varma, M., Lee, MW., Tamboli, P., Zarbo, RJ., Jimerez, RE. (2002)
Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle
biopsy specimens: a study of 250 consecutive cases in a routine surgical
pathology practice. Arch Pathol Lab Med (126), 554-561.

7
Vinjamoori, A., Jagannathan, J., Shinagere, A. (2012). Atypica metastases from
prostate cancer: 10-year experience at a single institution. AJR. Am J
Roentgenol (199), 367-72.

WHO World Health Organization. (2010). Prostate cancer in Asia. World Health
Organization Medical Centre. http://www.who.int/ diakses pada 27 Maret
2016.

Yang, XJ., McEntee, M., Epstein, JI. (1998). Distinction of basaloid carcinoma of
the prostate from benign basal cell lesions by using immunohistochemistry
for bcl-2 and Ki-67. Hum Pathol (29), 1447-1450.

Zhou, M, G. C. (2007). Genitourinary pathology: neoplasm of the prostate and


seminal vesicles. 56-84.

8
9

You might also like